DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

U.S. Army Medical Research and Materiel Command



Point of Contact:
Chuck Dasey, (301) 619-7071

April 28, 2000
For Immediate Release:
Department of Defense Ovarian Cancer Research Program for Fiscal Year 2000

The Fiscal Year (FY) 2000 Defense Appropriations Act provides $12M to continue the Department of Defense Ovarian Cancer Research Program (OCRP) administered by the U.S. Army Medical Research and Materiel Command through the Congressionally Directed Medical Research Programs (CDMRP).

The OCRP is seeking meritorious research focused on epithelial ovarian carcinoma and/or primary peritoneal carcinoma. Emphasis on one or more of the following research areas is encouraged: (1) etiology, (2) early detection/diagnosis, (3) preclinical therapeutics, and (4) quality of life.

The programmatic strategy for the OCRP FY00 is to fund proposals through two research award mechanisms: Ovarian Cancer New Investigator Awards and Program Project Awards. Detailed descriptions of each award mechanism, evaluation and eligibility criteria, and proposal submission requirements can be found in the FY00 Program Announcement. This document may be downloaded from the CDMRP web site at http://cdmrp.army.mil/ocrp.

Ovarian Cancer New Investigator Awards are designed to prepare independent investigators (Assistant Professor or equivalent with no more than 6 years of experience in the field of ovarian cancer research) for careers in ovarian cancer research and to attract more senior investigators new to the field of ovarian cancer research. Funding may be requested for an average of $100,000 per year in direct costs for a maximum of $300,000 over 3 years plus indirect costs as appropriate. Preliminary or pilot data are required.

Program Project Awards are designed to establish new synergistic multidisciplinary research programs. Program Projects will consist of a minimum of two and a maximum of four individual research projects and a minimum of one and a maximum of two supporting core facilities. Funding for Program Project Awards may be requested for a maximum of $2M, inclusive of direct and indirect costs, over a 2- to 4-year performance period. To extend infrastructure to a greater number of institutions, preference will be given to those that do not have active Program Project-type grants for ovarian cancer research at the release date of the OCRP FY00 Program Announcement.

The receipt deadline for Ovarian Cancer New Investigator and Program Project Award proposals is September 13, 2000 at 4 p.m. Eastern Time.

For more information about the OCRP and other CDMRP-sponsored programs and events, please visit the CDMRP web site at http://cdmrp.army.mil.